Evofem Biosciences (EVFM) Return on Equity [ROE] (2015 - 2020)
Evofem Biosciences' Return on Equity [ROE] was -684.89% in Q4 2020, down 281.81 percentage points from -403.08% a year earlier and down 474.44 percentage points from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Return on Equity [ROE] (2015 - 2020) Analysis & Trends
For FY2020, Return on Equity [ROE] at Evofem Biosciences came in at -1675.90%.
- Return on Equity [ROE] shows a five-year change of -1578.98 percentage points (FY2015 to FY2020).
- Quarterly Return on Equity [ROE] has moved between -2504.83% (Q2 2019) and -137.94% (Q3 2016) over five years.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2020 (a gain of 2222.12 percentage points); the worst was Q3 2017 (a drop of 1407.23 percentage points).
- Per Business Quant data, EVFM's Return on Equity [ROE] in the three quarters before Q4 2020 was -210.44% (Q3 2020), -282.71% (Q2 2020) and -973.90% (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.97% |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | -684.89% |
| Sep 30, 2020 | -210.44% |
| Jun 30, 2020 | -282.71% |
| Mar 31, 2020 | -973.90% |
| Dec 31, 2019 | -403.08% |
| Sep 30, 2019 | -274.93% |
| Jun 30, 2019 | -2,504.83% |
| Sep 30, 2017 | -1,545.17% |
| Jun 30, 2017 | -207.30% |
| Sep 30, 2016 | -137.94% |
| Jun 30, 2016 | -205.31% |
| Mar 31, 2016 | -199.85% |
| Dec 31, 2015 | -152.66% |
| Sep 30, 2015 | -90.16% |
| Jun 30, 2015 | -40.36% |
| Mar 31, 2015 | -23.20% |
API Access
Evofem Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();